The EpiPen maker is still in the news.
Lawmakers, consumers and parents of children subject to allergic emergencies continue to condemn Mylan.
The firm boosted the price of its EpiPens more than 500 percent from $94 after acquiring the product in 2007.
Mylan says it will sell a generic version.
Some analysts have estimated that the tiny amount of epinephrine in an EpiPen is worth barely $1, and the auto-injectors might cost as little as $5.